PubMed COVID-19 Clinical Care

COVID-19 has a dramatic impact on the use of public transport (PT). Most European cities report a decline in PT use during 2020 and 2021. Nevertheless, not all cities report similar decline patterns or comparable resilience paths. We investigate the

Although lung disease is the primary clinical outcome in COVID-19 patients, how SARS-CoV-2 induces lung pathology remains elusive. Here we describe a high-throughput platform to generate self-organizing and commensurate human lung buds derived from

No abstract

CONCLUSION: Virtual implementation of an intervention that combined EHR-based tools with practice redesign approaches increased AWV and preventive services utilization in Medicare patients. Given the success of this intervention during the COVID-19

No abstract

Olfactory dysfunction and neuropsychiatric symptoms are commonly reported by patients of coronavirus disease 2019 (COVID-19), a respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Evidence from recent

Covid-19 is a serious global infectious disease impairing the quality of life of people across the world. SARS-CoV-2 may reside in nasopharyngeal and salivary secretions of Covid-infected patients and spreads mainly through respiratory droplets and

INTRODCUTION: Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are major causes of COVID-19 mortality. However, drug delivery to lung tissues is impeded by endothelial cell barriers, limiting the efficacy of existing treatments

CONCLUSION: The present findings suggest caution when interpreting the effects of ageism on well-being during the pandemic, as those associations may already have existed pre-pandemic. The finding that perceptions of continued growth positively

CONCLUSIONS: The use of nitazoxanide, azithromycin, and prednisone proved to be effective as it resulted in improvement of symptoms and in successful outcomes for the management of COVID-19 outpatients.